Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal Root ganglion neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 3, 2009, Pages 1062-1070

  Liu, Qing ^a   Bhat, Manjunatha ^a   Bowen, Wayne D ^b   Cheng, Jianguo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; OSANETANT; RIMONABANT; THAPSIGARGIN; BENZOXAZINE DERIVATIVE; BORNANE DERIVATIVE; CALCIUM; CANNABINOID 2 RECEPTOR; MORPHOLINE DERIVATIVE; N METHYLASPARTIC ACID; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; ENDOPLASMIC RETICULUM; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPINAL GANGLION; ANIMAL; CELL LINE; CELL SURVIVAL; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MOUSE; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOXAZINES; BORNANES; CALCIUM; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; MICE; MORPHOLINES; N-METHYLASPARTATE; NAPHTHALENES; NEURONS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION;

EID: 73349099368     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.156216     Document Type: Article

References (47)

1. Abood ME, Rizvi G, Sallapudi N, and McAllister SD (2001) Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci Lett 309:197-201.
2. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, et al. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10:870-879.
3. Ben-Ari Y, Aniksztejn L, and Bregestovski P (1992) Protein kinase C modulation of NMDA currents: an important link for LTP induction. Trends Neurosci 15:333-339.
4. Boyd ST (2006) The endocannabinoid system. Pharmacotherapy 26:218S-221S.
5. Centonze D, Rossi S, Finazzi-Agrò A, Bernardi G, and Maccarrone M (2007) The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. Int Rev Neurobiol 82:171-186.
6. Chen J, Lee CT, Errico S, Deng X, Cadet JL, and Freed WJ (2005) Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d- aspartate-induced AF5 cell death. Brain Res Mol Brain Res 134:215-225.
7. 2+ stores in rat sympathetic neurons. Proc Natl Acad Sci U S A 95:7151-7156.
8. Dedov VN, Mandadi S, Armati PJ, and Verkhratsky A (2001) Capsaicin-induced depolarisation of mitochondria in dorsal root ganglion neurons is enhanced by vanilloid receptors. Neuroscience 103:219-226.
9. Marzo V and Petrosino S (2007) Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 18:129-140.
10. Docagne F, Muñetón V, Clemente D, Ali C, Loría F, Correa F, Hernangómez M, Mestre L, Vivien D, and Guaza C (2007) Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol Cell Neurosci 34:551-561.
11. Drake MT, Violin JD, Whalen EJ, Wisler JW, Shenoy SK, and Lefkowitz RJ (2008) β-Arrestin-biased agonism and β2-adrenergic receptor. J Biol Chem 283:5669-5676.
12. Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, Ferro ES, Scarlata S, Fricker LD, and Devi LA (2009) Novel endogenous peptide agonists of cannabinoid receptors. FASEB J 23:3020-3029.
13. Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ, and Bickler PE (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 70:671-676.
14. Harvey J and Collingridge GL (1992) Thapsigargin blocks the induction of long-term potentiation in rat hippocampal slices. Neurosci Lett 139:197-200.
15. Howlett AC and Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108:53-70.
16. Iversen L and Chapman V (2002) Cannabinoids: a real prospect for pain relief? Curr Opin Pharmacol 2:50-55.
17. Johnson EM Jr, Koike T, and Franklin J (1992) A "calcium set-point hypothesis" of neuronal dependence on neurotrophic factor. Exp Neurol 115:163-166.
18. Kim SH, Won SJ, Mao XO, Jin K, and Greenberg DA (2006) Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol Pharmacol 69:691-696.
19. Kotecha SA and MacDonald JF (2003) Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission. Int Rev Neurobiol 54:51-106.
20. 2+ sensitivity in rat dorsal horn neurons. J Physiol 495:449-463.
21. Lauckner JE, Hille B, and Mackie K (2005) The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci U S A 102:19144-19149.
22. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, and Mackie K (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 105:2699-2704.
23. Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD, and MacDonald JF (1999) G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 2:331-338.
24. Marsicano G, Moosmann B, Hermann H, Lutz B, and Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448-456.
25. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
26. Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
27. 2+ signals in cerebellar granule neurons in culture. J Neurosci 19:8765-8777.
28. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334:661-665.
29. Pacher P, Bátkai S, and Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389-462.
30. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
31. Pertwee RG (2007) Cannabinoids and multiple sclerosis. Mol Neurobiol 36:45-59.
32. Pertwee RG and Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66:101-121.
33. Qiu Z, Parsons KL, and Gruol DL (1995) Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J Neurosci 15:6688-6699.
34. Reichling DB and MacDermott AB (1993) Brief calcium transients evoked by glutamate receptor agonists in rat dorsal horn neurons: fast kinetics and mechanisms. J Physiol 469:67-88.
35. Richter F, Meurer BH, Zhu C, Madvedeva VP, and Chesselet MF (2009) Neurons express hemoglobin α and β chains in rat and human brains. J Comp Neurol 515:538-547.
36. Shen M and Thayer SA (1998) Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 54:459-462.
37. 2+ responses to N-methyl-D- aspartate and depolarization in cerebellar granule cells. J Neurochem 61:760-763.
38. Tong G, Shepherd D, and Jahr CE (1995) Synaptic desensitization of NMDA receptors by calcineurin. Science 267:1510-1512.
39. van der Stelt M and Di Marzo V (2005) Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med 7:37-50.
40. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329-332.
41. Walker JM and Hohmann AG (2005) Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol. 168:509-554.
42. Woolf CJ (1983) Evidence for a central component of post-injury pain hypersensitivity. Nature 306:686-688.
43. Woolf CJ and Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.
44. i elevation. J Neurophysiol 81:781-787.
45. Yankura K, Zhang HY, and Bhat MB (2003) Role of vanilloid receptor in the capacitative calcium entry in sensory neurons. Anesthesiology 99:A764.
46. Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, and O'Donnell D (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 17:2750-2754.
47. Zhuang SY, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE, and Deadwyler SA (2005) Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48:1086-1096.